Javascript must be enabled to continue!
Cancer Chemoprevention by Carotenoids
View through CrossRef
Carotenoids are natural fat-soluble pigments that provide bright coloration to plants and animals. Dietary intake of carotenoids is inversely associated with the risk of a variety of cancers in different tissues. Preclinical studies have shown that some carotenoids have potent antitumor effects both in vitro and in vivo, suggesting potential preventive and/or therapeutic roles for the compounds. Since chemoprevention is one of the most important strategies in the control of cancer development, molecular mechanism-based cancer chemoprevention using carotenoids seems to be an attractive approach. Various carotenoids, such as β-carotene, a-carotene, lycopene, lutein, zeaxanthin, β-cryptoxanthin, fucoxanthin, canthaxanthin and astaxanthin, have been proven to have anti-carcinogenic activity in several tissues, although high doses of β-carotene failed to exhibit chemopreventive activity in clinical trials. In this review, cancer prevention using carotenoids are reviewed and the possible mechanisms of action are described.
Title: Cancer Chemoprevention by Carotenoids
Description:
Carotenoids are natural fat-soluble pigments that provide bright coloration to plants and animals.
Dietary intake of carotenoids is inversely associated with the risk of a variety of cancers in different tissues.
Preclinical studies have shown that some carotenoids have potent antitumor effects both in vitro and in vivo, suggesting potential preventive and/or therapeutic roles for the compounds.
Since chemoprevention is one of the most important strategies in the control of cancer development, molecular mechanism-based cancer chemoprevention using carotenoids seems to be an attractive approach.
Various carotenoids, such as β-carotene, a-carotene, lycopene, lutein, zeaxanthin, β-cryptoxanthin, fucoxanthin, canthaxanthin and astaxanthin, have been proven to have anti-carcinogenic activity in several tissues, although high doses of β-carotene failed to exhibit chemopreventive activity in clinical trials.
In this review, cancer prevention using carotenoids are reviewed and the possible mechanisms of action are described.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
New Spectral Indices as Indicators of Carotenoids Content
New Spectral Indices as Indicators of Carotenoids Content
Carotenoids play a key role in adaptation of plants to light stress and other unfavorable ecological conditions. Remote sensing of carotenoids content still not well developed due ...
Screening Breast MRI, Chemoprevention, and Risk-Reducing Surgeries in Unaffected BRCA Carriers.
Screening Breast MRI, Chemoprevention, and Risk-Reducing Surgeries in Unaffected BRCA Carriers.
Abstract
BACKGROUND: BRCA testing has identified hundreds of families with deleterious BRCA1 and BRCA2 mutations at the University of California, San Francisco (UCSF...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract
Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Comprehensive update on cancer scenario of Bangladesh
Comprehensive update on cancer scenario of Bangladesh
AbstractBangladesh, at 142 million people, is the ninth most populous country in the world. There are 13 to 15 lakh cancer patients in Bangladesh, with about two lakh patients newl...
Morphological plaque characteristics and clinical outcomes of acute coronary syndrome patients with a cancer history
Morphological plaque characteristics and clinical outcomes of acute coronary syndrome patients with a cancer history
Abstract
Background
Although previous studies have reported that patients with a history of cancer have 2–3 times higher risks f...

